PubGene has had dialogue with Norwegian health authorities on a possible role for establishing an information channel on the COVID-19 virus, with continuous update
PubGene’s project proposal ‘Coremine Vitae: Realising the promise of precision medicine for cancer patients and their healthcare providers with biomedical intelligence reporting’ submitted for the European Innovation
PubGene has conducted a first Coremine Vitae within the neuro diseases. We successfully provided an epilepsy patient with information on disease characteristics and drugs.
The Coremine Medical service is upgraded with new features. Please register to the service here: https://coremine.com/medical/
CEO Håvard Hauge presented PubGene and Coremine Vitae at EHiN – Norway’s e-health conference – gathering 1650 national and international delegates. The audience was
PubGene has signed an innovation contract with the medical clinic Moloklinikken AS. The main objective is to define, develop and streamline the Coremine Vitae
PubGene collaborates with the Section for Research and Innovation at Haukeland University Hospital. Haukeland facilitates increased quality and quantity of clinical research, so that
Nansen Neuroscience Network is a non-profit life science organization which are set up to accelerate innovation from Nordic neuroscience research. Much of the work
